Home>Topics>Stocks>Laboratory Corporation of America Holdings

Laboratory Corporation of America Holdings

  1. All
  2. Commentary
  3. Fund Reports
  4. Headlines
  1. Laboratory Corporation of America Holdings' ( LH ) CEO David King on Q2 2014 Results - Earnings Call Transcript

    Headlines

    Fri, 18 Jul 2014

    Laboratory Corporation of America Holdings (NYSE: LH ) Q2 2014 Results Earnings Conference Call July ..... gentlemen, and welcome to the Second Quarter 2014 Laboratory Corporation of America Holdings Earnings Conference Call. My name is Glenn and

  2. Laboratory Corporation of America beats by $0.07, beats on revenue

    Headlines

    Fri, 18 Jul 2014

    Laboratory Corporation of America (NYSE: LH ): Q2 EPS of $1.84 beats by $0.07 . Revenue of $1.52B (+3.4% Y/Y) beats by $20M . Press Release Post your comment!

  3. LabCorp Meets Fourth-Quarter Expectations and Ramps Up Investment for 2013

    Commentary

    Fri, 8 Feb 2013

    LabCorp LH released fourth-quarter and full-year results that generally met our expectations, and we are leaving our $98 fair ..... reimbursement reductions in order to earn economic profits. The firm has just rolled out its new Propel robotic system in its key laboratory in Burlington, N.C. This automation should replace work that is currently done by hand, thereby increasing efficiency

  4. LabCorp target of massive private equity buyout -report

    Headlines

    Tue, 31 Jul 2012

    July 31 (Reuters) - A private equity consortium is aiming to scoop-up lab-testing company, Laboratory Corporation of America Holdings in a huge leveraged buyout and take it private, Mergermarket...

  5. SCOBX DWS Global Thematic S Fund Analysis, Report, Research, 5 Star Rating – Morningstar

    Fund Reports

    Wed, 28 Jul 2010

    genetic structure , which Kratz thinks will grow immensely in importance , explains the presence of Life Technologies LIFE and Laboratory Corp . of America LH in the portfolio's top 20 . He's also willing to go where many others steer clear , recently buying the Greek stock exchange

  6. MUHLX Muhlenkamp Fund Analysis, Report, Research, 5 Star Rating – Morningstar

    Fund Reports

    Thu, 25 Mar 2010

    historical average weighting . But Muhlenkamp isn't looking to play defense . He simply thinks firms such as Pfizer PFE and Laboratory Corporation of America LH are trading too cheaply due to the specter of health - care reform . Similarly , he sees a lot of value - - as well as potential

  7. MDHCX BlackRock Healthcare Inv A Fund Analysis, Report, Research, 5 Star Rating – Morningstar

    Fund Reports

    Wed, 5 Aug 2009

    s stake late in 2008. By contrast, he added to positions in diagnostic lab firms, such as Quest Diagnostics DGX and Laboratory Corporation of America LH , as both would likely be beneficiaries of proposed regulatory reform (as greater numbers of people move into the health

  8. Solid Results in LabCorp's 2Q

    Commentary

    Thu, 23 Jul 2009

    We're holding steady on our fair value estimate for Laboratory Corporation of America LH following the release of second-quarter results. Sales increased 3.6% from the prior-year period. The revenue gain was

  9. Slower Growth for Labs in 2009

    Commentary

    Tue, 20 Jan 2009

    In the next few weeks, independent lab operators Laboratory Corporation of America LH and Quest Diagnostics DGX will report fourth-quarter and year-end results. At this point, we're keeping our fair value

  10. Solid 3Q for LabCorp

    Commentary

    Thu, 23 Oct 2008

    On Thursday, Laboratory Corporation of America LH reported third-quarter results that met our expectations, and we're sticking with our fair value estimate. Revenue increased

« Prev123Next »
Content Partners